Linked Life Data

13679682

Source:http://linkedlifedata.com/resource/pubmed/id/13679682

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5-6
pubmed:dateCreated
2003-9-24
pubmed:abstractText
Recently, it has become clear that the concept of gene therapy has changed. Whilst it was once thought that gene therapy merely required insertion of a transgene into a gene transfer vector with subsequent delivery to the target tissue to provide a therapeutic effect, this is now entirely too simplistic. Rather, there are many critical steps in the design and implementation of gene medicines and each step requires exhaustive testing and optimisation for a given target disease to increase efficiency and safety. Within cardiovascular diseases there are many potential target pathologies for gene-based interventions. Bypass graft failure and restenosis are two such examples.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1424-8832
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
389-91
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Gene therapy for bypass graft failure and restenosis.
pubmed:affiliation
Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, G11 6NT, UK. ab11f@clinmed.gla.ac.uk
pubmed:publicationType
Journal Article, Review